Contact
Please use this form to send email to PR contact of this press release:
Axim® Biotechnologies Earns GMP License From Dutch Ministry of Health to Produce Cannabinoid-Based Pharmaceutical Products
TO:
Please use this form to send email to PR contact of this press release:
Axim® Biotechnologies Earns GMP License From Dutch Ministry of Health to Produce Cannabinoid-Based Pharmaceutical Products
TO: